Blüm Technologies Group is pleased to announce the acquisition of Triscribe, an innovative provider of medicines optimisation and ePMA analytics solutions for the NHS. This acquisition marks a significant step in Blüm’s commitment to helping healthcare organisations reduce unnecessary spending, improve patient safety, and accelerate digital transformation across the health and care system.
Triscribe’s platform provides detailed insight into prescribing and medicines administration, enabling NHS Trusts to better understand clinical behaviours, identify unwarranted variation, and make evidence-based improvements. By integrating Triscribe into the Blüm ecosystem, the group can offer a more comprehensive suite of digital tools focused on safety, efficiency, and clinical performance.
Blüm Technologies Group delivers end-to-end digital health services across software engineering, AI development, and regulatory support. Its work spans public and private health sectors internationally, with deep experience in developing transformation strategies, technical infrastructure, and ensuring clinical and data governance.
The addition of Triscribe complements Blüm’s mission to drive measurable improvement in patient outcomes. Together, the two organisations will empower NHS partners to make smarter, data-driven decisions around prescribing, improve medication safety, and support frontline clinical teams with actionable insights.
Dr Michael Watts, Co-Founder and CEO of Blüm Technologies Group, said:
“Triscribe brings deep domain expertise and a proven solution that’s already delivering value to NHS organisations. This acquisition strengthens our ability to support clinical teams with real-time intelligence and creates new opportunities to drive impact at scale. It also reflects our commitment to supporting founders, preserving talent, and ensuring continuity of service between SMEs and the NHS.”
This is the latest in a series of strategic moves by Blüm Technologies Group to build a resilient and interoperable digital health ecosystem—capable of supporting the full spectrum of healthcare innovation, from early-stage development to enterprise-scale deployment.
To learn more about Triscribe, visit https://triscribe.net
Written and provided by Medilink Midlands Member.
